Masato Kataoka

Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07

Yoshihiro Kakeji, Kazuhiro Yoshida, Yasuhiro Kodera et al. · Gastric Cancer · 2021 · 90 citations · Full text

Medicine, Oncology, Chemotherapy +6

Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis

Chu Matsuda, Yoshinori Munemoto, Hideyuki Mishima et al. · Cancer Chemotherapy and Pharmacology · 2015 · 81 citations · Full text

Pharmacy, Oncology, Pharmacology +17

<i>RAS</i> Mutations in Circulating Tumor DNA and Clinical Outcomes of Rechallenge Treatment With Anti-EGFR Antibodies in Patients With Metastatic Colorectal Cancer

Yu Sunakawa, Masato Nakamura, Masahiro Ishizaki et al. · JCO Precision Oncology · 2020 · 47 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Aberrant Elevation of Tyrosine‐specific Phosphorylation in Human Gastric Cancer Cells

Eisuke Takeshima, Michinari Hamaguchi, Tadashi Watanabe et al. · Japanese Journal of Cancer Research · 1991 · 36 citations · Full text

Medicine, Molecular Biology, Oncology +17

Severe complications of mediastinal pancreatic pseudocyst: report of esophagobronchial fistula and hemothorax

Akira Tanaka, Ryoji Takeda, Hirofumi Utsunomiya et al. · Journal of Hepato-Biliary-Pancreatic Surgery · 2000 · 26 citations

Medicine, Internal Medicine, Surgery +11